Navigation Links
MAQUET Opens North America's First VARIOP Prefabricated Operating Suite System, Allowing Space Reconfiguration in Hours, Less Disruption Than Traditional Construction
Date:1/6/2009

BRIDGEWATER, N.J., Jan. 6 /PRNewswire/ -- MAQUET Inc., a subsidiary of the Swedish-based Getinge Group and one of the oldest and largest surgical equipment companies in the world, has announced that it has completed North America's first installation of its advanced, prefabricated VARIOP operating room system in Spartanburg, S.C.

VARIOP now enables hospitals and surgical centers to reconfigure spaces very quickly with minimal disruption, versus what hospitals experience with traditional construction.

MAQUET recently completed the installation of 12 VARIOP operating suites at Spartanburg Regional Medical Center, with 5 more suites scheduled to be completed in 2009. The VARIOP suites are being used by the hospital for procedures ranging from routine surgeries to robotic surgeries. While MAQUET has installed VARIOP at more than 2,000 hospitals globally, this marks the first North American installation.

"VARIOP, for the first time, will allow hospitals to reconfigure operating suites in a short amount of time, which significantly reduces downtime and disruption from construction effects," said Kevin Gilroy, Senior Business Development Director for MAQUET. "VARIOP's incredible flexibility allows for installation in spaces of different sizes, giving hospitals the ability to easily modify or upgrade the operating rooms as newer technology becomes available. VARIOP, therefore, has the potential to save hospitals a significant amount of money."

VARIOP contains a number of features not usually found in traditional operating rooms, including:

  • Suspended metal ceilings for quick installation of products such as ambient room lights, air conditioning equipment or ceiling mounted medical equipment
  • Sliding doors that create much less air turbulence than swing doors, and provide for more efficient use of space in the OR
  • Special-purpose, easy-to-cle
    '/>"/>

SOURCE MAQUET Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related medicine news :

1. ARJO / Getinge / Maquet Announces New West Coast Showroom Opening
2. MAQUET Cardiovascular Announces Patent Infringement Complaints Against Terumo
3. MAQUET Cardiovascular Launches HEARTSTRING III Proximal Seal System for Coronary Artery Bypass Graft Surgery
4. Cardica, Intuitive Surgical, MAQUET Cardiovascular and Transonic to Host Innovations in Revascularization Symposium
5. MAQUET Cardiovascular Responds to Terumo Complaint About VASOVIEW Endoscopic Vessel Harvesting Systems
6. R&J Public Relations Selected to Promote MAQUET Inc.s VARIOP Operating Room Suite in North America
7. Terumo Corporation Announces Settlement of all Patent Litigation with Maquet Cardiovascular
8. Online Celebrity Shoe Charity Auction for Womens Heart Health Opens Bidding
9. An Innovation in Health Care Opens at a CVS/pharmacy Store in the Oklahoma City Region
10. Concentra Opens On-Site Medical Unit at World Trade Center Site
11. Navitas Opens New Cancer Rehabilitation Center in Albuquerque in Conjunction With New Mexico Cancer Centers

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/28/2009)...tudy finds gene variation believed to affect circa...ealthDay News) -- New research suggests that an in...a factor in the development of bipolar disorder in...ination of the genetic makeup of 152 children with...le to major mood swings, and 140 children without ...
(Date:11/27/2009)... Biotech firm Replikins Lt... the H1N1 virus genomic data. It shows that the l... 3.7 (s.d. 4.5) during the virus,s current outbrea...vels this week of 2.0 (s.d. 0.1). The H1N1 infecti... Boston (PRWEB) November 27, 2009 ...
(Date:11/27/2009)..., , NEUILLY-SUR-SEINE, France, Nov. 27 /P...erican professional cycling team dedicated to ethi... cycling champions, announced today that it will b... Transitions Optical as a new sponsor of the team....cturer of adaptive eyewear, offering the most adva...
(Date:11/27/2009)...oaring rates to bring unprecedented medical, econo...Nov. 27 (HealthDay News) -- The number of people w...ouble over the next 25 years, a new study predicts... 44.1 million people with the disease, up from 23....of treating people with diabetes will triple, the ...
(Date:11/27/2009)... Specialist manufacturers ...roducts are saving millions of dollars by bringing... process. Increasing numbers of pro-active medical...perts at the concept stage of their projects, ensu...ting design processes or potentially outdated tech...
Breaking Medicine News(10 mins):Health News:Bipolar Disorder May Be Tied to Body Clock 2Health News:Lethality of H1N1 Virus Drops to "Non-Epidemic Resting Levels" in Current Cycle; Virus' Infectivity Remains Increased 2Health News:Lethality of H1N1 Virus Drops to "Non-Epidemic Resting Levels" in Current Cycle; Virus' Infectivity Remains Increased 3Health News:Lethality of H1N1 Virus Drops to "Non-Epidemic Resting Levels" in Current Cycle; Virus' Infectivity Remains Increased 4Health News:Lethality of H1N1 Virus Drops to "Non-Epidemic Resting Levels" in Current Cycle; Virus' Infectivity Remains Increased 5Health News:Team Garmin-Slipstream Officially Re-named Team Garmin-Transitions With Addition of Transitions Optical as New Sponsor 2Health News:Team Garmin-Slipstream Officially Re-named Team Garmin-Transitions With Addition of Transitions Optical as New Sponsor 3Health News:Diabetes Cases Expected to Double in 25 Years 2Health News:Diabetes Cases Expected to Double in 25 Years 3Health News:Pro-active Manufacturers Save Millions with Advanced Flintec Medical Load Cells 2Health News:Pro-active Manufacturers Save Millions with Advanced Flintec Medical Load Cells 3Health News:Pro-active Manufacturers Save Millions with Advanced Flintec Medical Load Cells 4
...archers at the Harvard Medical School it is said t... chronically infected cystic fibrosis (CF) patient...which secretes proteins that cause disease in the ...ay be a cancer patient with a weakened immune syst...
...on placed new restrictions on a doctors’ role i...st any policy //that gives medical professionals ...to use harsher tactics than they would in the abs...roups and medical ethicists. They charge that doct...
...ar excuse "not tonight, I have a headache," a new ...xual activity and says that sexual desire and migr... // In fact, migraine sufferers reported hig...eagues. 'Migraine patients in general may exp...
...lthcare products Regulatory Agency (MHRA) warned t...eadings. The diabetic patients are cautioned about...d to giving readings which were far too high. Diab...nsulin resulting in hypoglycaemic coma. It is...
...in San Diego, California, Allerca, Inc., is now t...kitten, the world’s first hypoallergenic cats //.T...o are also cat lovers. Allerca sources claim ...ng. Hence these animals were not transgenic,in oth...
...s at the Johns Hopkins Bloomberg School of Public ...lar immune tactics to ward off bacterial// pathoge...wn on the different genes connected with the prote...rtant for the resistance to bacterial infection. H...
Other Medicine News:Health News:Treatment of Bacterial Infection Paves the Way to Treat CF Infection 2Health News:Medical Role In Interrogations Curtailed By Pentagon 2Health News:What Ticks the Mosquito immune system? 2
(Date:11/25/2009)...W YORK, Nov. 25 Reportlinker.com a...lable in its catalogue: ,, Mammography Equipm...www.reportlinker.com/p0164330/Mammography-Equipmen... incidence of breast cancer in industrialized as w...fluencing growth in the mammography market. Global...
(Date:11/25/2009)...EL HILL, N.C., Nov. 25 Cempra Phar...Fernandes, president and chief executive officer, ...th Care Conference at 8:50 a.m. EST, December 1, 2.... Dr. Fernandes will provide an overview of the c...for the treatment of drug-resistant pathogens incl...
(Date:11/25/2009)...VIEW, Calif., Nov. 25 ChemoCentr...al data from the Company,s PROTECT-1 (the Prospect...disease Trial) of Traficet-EN(TM) (CCX282-B) in pa...onstrated clinical efficacy with a favorable safet...d evidence of clinical efficacy in the reduction o...
Breaking Medicine Technology:Reportlinker Adds Mammography Equipment - A Global Market Perspective 2Reportlinker Adds Mammography Equipment - A Global Market Perspective 3Reportlinker Adds Mammography Equipment - A Global Market Perspective 4Reportlinker Adds Mammography Equipment - A Global Market Perspective 5Reportlinker Adds Mammography Equipment - A Global Market Perspective 6Reportlinker Adds Mammography Equipment - A Global Market Perspective 7Reportlinker Adds Mammography Equipment - A Global Market Perspective 8ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 2ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 3ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 4ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 5ChemoCentryx Reports Positive PROTECT-1 Study Results for Traficet-EN(TM) at the GASTRO 2009 UEGW/WCOG Conference 6Are breast cancer patients being kept in the dark 3F 50933 1Are breast cancer patients being kept in the dark 3F 50933 2One step closer to an artificial nerve cell 50931 1One step closer to an artificial nerve cell 50931 2Severe COPD may lead to cognitive impairment 50929 1Severe COPD may lead to cognitive impairment 50929 2Severe COPD may lead to cognitive impairment 50929 3
..." Study Also Showed Arzoxifene Significantly Suppr...ostmenopausal Women with Osteoporosis , , ATHENS,...LLY ) presented new data showing arzoxifene, an in...r (SERM), was superior to raloxifene at increasing...otal hip and femoral neck, and at suppressing bone...
...20 Santaris Pharma announced today that,the fourt... In the USA,several patients with cancer have now ..., which is jointly developed by Santaris Pharma an...ministration (FDA) recently,accepted Enzon PharmaÂ...tion,for the use of the LNA-based Survivin inhibit...
Other Medicine Technology:Phase III Trial Showed Investigational Compound Arzoxifene Was Superior to Evista(R) (raloxifene HCl) in Increasing BMD in Postmenopausal Women with Osteoporosis 2Phase III Trial Showed Investigational Compound Arzoxifene Was Superior to Evista(R) (raloxifene HCl) in Increasing BMD in Postmenopausal Women with Osteoporosis 3Phase III Trial Showed Investigational Compound Arzoxifene Was Superior to Evista(R) (raloxifene HCl) in Increasing BMD in Postmenopausal Women with Osteoporosis 4Phase III Trial Showed Investigational Compound Arzoxifene Was Superior to Evista(R) (raloxifene HCl) in Increasing BMD in Postmenopausal Women with Osteoporosis 5Another LNA-based RNA Inhibitor Enters Clinical Trials 2Another LNA-based RNA Inhibitor Enters Clinical Trials 3
...tional reference laboratory and a worldwide leader.... ARUP offers an extensive test menu of highly com...omic pathology. Owned by the University of Utah, A...f the nation's university teaching hospitals and c...
...tional reference laboratory and a worldwide leader.... ARUP offers an extensive test menu of highly com...omic pathology. Owned by the University of Utah, A...f the nation's university teaching hospitals and c...
...tional reference laboratory and a worldwide leader.... ARUP offers an extensive test menu of highly com...omic pathology. Owned by the University of Utah, A...f the nation's university teaching hospitals and c...
...tional reference laboratory and a worldwide leader.... ARUP offers an extensive test menu of highly com...omic pathology. Owned by the University of Utah, A...f the nation's university teaching hospitals and c...
Medicine Products: